- Home
- BGLC vs APDN Comparison
BGLC vs APDN Comparison
Compare BGLC & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- APDN
- Stock Information
- Founded
- BGLC 2017
- APDN 1983
- Country
- BGLC Malaysia
- APDN United States
- Employees
- BGLC N/A
- APDN N/A
- Industry
- BGLC Medical Specialities
- APDN Other Consumer Services
- Sector
- BGLC Health Care
- APDN Consumer Discretionary
- Exchange
- BGLC Nasdaq
- APDN Nasdaq
- Market Cap
- BGLC 5.0M
- APDN 4.2M
- IPO Year
- BGLC N/A
- APDN N/A
- Fundamental
- Price
- BGLC $6.41
- APDN $4.50
- Analyst Decision
- BGLC
- APDN
- Analyst Count
- BGLC 0
- APDN 0
- Target Price
- BGLC N/A
- APDN N/A
- AVG Volume (30 Days)
- BGLC 2.7M
- APDN 140.8K
- Earning Date
- BGLC 08-13-2025
- APDN 08-07-2025
- Dividend Yield
- BGLC N/A
- APDN N/A
- EPS Growth
- BGLC N/A
- APDN N/A
- EPS
- BGLC N/A
- APDN N/A
- Revenue
- BGLC $9,265,870.00
- APDN $3,790,616.00
- Revenue This Year
- BGLC N/A
- APDN $57.08
- Revenue Next Year
- BGLC N/A
- APDN $40.00
- P/E Ratio
- BGLC N/A
- APDN N/A
- Revenue Growth
- BGLC N/A
- APDN N/A
- 52 Week Low
- BGLC $2.01
- APDN $4.37
- 52 Week High
- BGLC $15.60
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- BGLC 60.18
- APDN 35.16
- Support Level
- BGLC $5.56
- APDN $4.38
- Resistance Level
- BGLC $15.60
- APDN $5.10
- Average True Range (ATR)
- BGLC 0.96
- APDN 0.53
- MACD
- BGLC 0.52
- APDN 0.40
- Stochastic Oscillator
- BGLC 29.46
- APDN 22.32
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.